{
    "clinical_study": {
        "@rank": "119323", 
        "arm_group": {
            "arm_group_label": "Mild Pericoronitis", 
            "description": "Those with mild signs/symptoms of pericoronitis affecting at least one lower 3rd molar with adjacent 2nd molar will be monitored for 12 months following study entry or 3 months for those electing to have 3rd molar extraction."
        }, 
        "biospec_descr": {
            "textblock": "GCF samples. biofilm samples serum samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this research study is to find out if the infection around 3rd molars and the\n      resulting inflammation around the gum also produces a general systemic inflammation."
        }, 
        "brief_title": "Third Molar Clinical Trials: Pericoronitis Studies", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pericoronitis", 
        "condition_browse": {
            "mesh_term": "Pericoronitis"
        }, 
        "detailed_description": {
            "textblock": "Relate signs and symptoms of mild pericoronitis, an oral clinical condition characterized by\n      intense inflammation and pain around a lower 3rd molar, to indicators of oral and systemic\n      inflammation in patients seeking treatment for the condition."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mild signs/symptoms of pericoronitis affecting at least one lower 3rd molar with\n             adjacent 2nd molar (spontaneous pain with localized swelling, purulence/drainage)\n             with recommended treatment being removal of 3rd molars,\n\n          -  Age 18 - 35 years,\n\n          -  ASA I, II health status,\n\n          -  AAP 1-3 periodontal status,\n\n          -  Willingness to participate in the study,\n\n          -  Geographic proximity to UNC.\n\n        Exclusion Criteria:\n\n          -  Major signs/symptoms of pericoronitis (Temperature >101 , dysphagia, limited mouth\n             opening <20mm incisor, facial swelling/cellulitis, severe uncontrolled discomfort),\n\n          -  ASA III, IV health status,\n\n          -  Medical contraindication to full mouth periodontal probing,\n\n          -  AAP 4 periodontal status,\n\n          -  Antibiotic treatment within the past 2 months,\n\n          -  Current tobacco use,\n\n          -  BMI > 29,\n\n          -  Pregnancy,\n\n          -  Non English speaking."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Those with mild signs/symptoms of pericoronitis affecting at least one lower 3rd molar\n        with adjacent 2nd molar with recommended treatment being removal of 3rd molars."
            }
        }, 
        "enrollment": {
            "#text": "115", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01882270", 
            "org_study_id": "05-2846"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pericoronitis", 
            "periodontal"
        ], 
        "lastchanged_date": "February 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599-7450"
                }, 
                "name": "UNC School of Dentistry"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pericoronitis; Oral and Systemic Inflammation", 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Ray White, DDS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "HRQOL data each day for seven days: Subject diary Pain 7pt Likert scale for worst/average pain in past 24h Gracely Scales for current sensory perception/affect Lifestyle, oral function, other symptoms 5pt Likert type scale Global QOL OHIP 14", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01882270"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "For enrolled patients with minor signs and symptoms of pericoronitis:\nAssess oral inflammation\nLevels of  \"orange/red complex\" anaerobic bacteria in biofilm samples from distal of all 2nd molars and distal of affected 3rd molar.\nLevels of GCF inflammatory mediators, PGE2 and IL-1\u00df from distal of all 2nd molars and mesial of 1st molars. If the first molar is absent, the mesial of the next most anterior tooth in the quadrant.\nAssess the possible association between oral inflammation and systemic inflammation -Serum C-Reactive Protein and IL-6 levels at the time of active symptoms", 
            "measure": "inflammatory mediators", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}